Target Healthcare REIT (LON:THRL) Sets New 1-Year High – Time to Buy?

Target Healthcare REIT (LON:THRL – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Monday. The stock traded as high as GBX 119.20 and last traded at GBX 118, with a volume of 75,574 shares changing hands. The stock had previously closed at GBX 117.20.

Analyst Ratings Changes

Separately, Jefferies Financial Group reissued a “buy” rating and issued a GBX 124 target price on shares of Target Healthcare REIT in a report on Wednesday. One research analyst has rated the stock with a Buy rating. According to MarketBeat, the company has an average rating of “Buy” and a consensus price target of GBX 124.

Get Our Latest Research Report on THRL

Target Healthcare REIT Stock Performance

The firm has a market cap of £744.71 million, a P/E ratio of 9.01, a P/E/G ratio of 1.48 and a beta of 0.71. The firm’s fifty day simple moving average is GBX 113.17 and its 200 day simple moving average is GBX 108.36.

Target Healthcare REIT (LON:THRL – Get Free Report) last issued its earnings results on Wednesday, September 23rd. The company reported GBX 13.32 earnings per share (EPS) for the quarter. Target Healthcare REIT had a return on equity of 11.03% and a net margin of 114.60%. On average, equities research analysts predict that Target Healthcare REIT will post 6.22 earnings per share for the current year.

About Target Healthcare REIT

(Get Free Report)

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.

Featured Stories

Receive News & Ratings for Target Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.